AC
IBB icon

Avestar Capital’s iShares Biotechnology ETF IBB Stock Holding History

Avestar Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-45
Closed -$4K – 473
2019
Q2 		$4K Hold
45
– – ﹤0.01% 605
2019
Q1 		$5K Sell
45
-11,830
-100% -$1.3M ﹤0.01% 565
2018
Q4 		$1.13M Buy
11,875
+11,830
+26,289% +$1.26M 0.77% 32
2018
Q3 		$5K Hold
45
– – ﹤0.01% 547
2018
Q2 		$4K Hold
45
– – ﹤0.01% 603
2018
Q1 		$4K Sell
45
-273
-86% -$30.3K ﹤0.01% 574
2017
Q4 		$33K Buy
+318
New +$34K 0.02% 290

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Avestar Capital's IBB Position: Q3 2019 in Review

Avestar Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 45 shares — an estimated $4K sold.

Avestar Capital first reported a position in IBB in Q4 2017 and held it in 7 quarters. The position peaked at $1.13M in Q4 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Avestar Capital reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Avestar Capital sold 45 iShares Biotechnology ETF shares in Q3 2019, an estimated $4K.
  • Avestar Capital first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 7 quarters.
  • Avestar Capital's iShares Biotechnology ETF position peaked at $1.13M in Q4 2018.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.